1. Walsh SR, Hogg D, Mydlarski PR. Bullous pemphigoid: from bench to bedside. Drugs. 2005; 65:905–926. PMID:
15892587.
2. Bernard P, Vaillant L, Labeille B, Bedane C, Arbeille B, Denoeux JP, et al. Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Bullous Diseases French Study Group. Arch Dermatol. 1995; 131:48–52. PMID:
7826096.
Article
3. Langan SM, Smeeth L, Hubbard R, Fleming KM, Smith CJ, West J. Bullous pemphigoid and pemphigus vulgaris--incidence and mortality in the UK: population based cohort study. BMJ. 2008; 337:a180. PMID:
18614511.
Article
4. Gudi VS, White MI, Cruickshank N, Herriot R, Edwards SL, Nimmo F, et al. Annual incidence and mortality of bullous pemphigoid in the Grampian Region of North-east Scotland. Br J Dermatol. 2005; 153:424–427. PMID:
16086760.
Article
5. Stanley JR, Hawley-Nelson P, Yuspa SH, Shevach EM, Katz SI. Characterization of bullous pemphigoid antigen: a unique basement membrane protein of stratified squamous epithelia. Cell. 1981; 24:897–903. PMID:
7018697.
Article
6. Sami N, Bhol KC, Beutner EH, Plunkett RW, Leiferman KM, Foster CS, et al. Simultaneous presence of mucous membrane pemphigoid and pemphigus vulgaris: molecular characterization of both autoantibodies. Clin Immunol. 2001; 100:219–227. PMID:
11465951.
7. Sami N, Ahmed AR. Dual diagnosis of Pemphigus and pemphigoid. Retrospective review of thirty cases in the literature. Dermatology. 2001; 202:293–301. PMID:
11455140.
8. Schmidt E, Zillikens D. Modern diagnosis of autoimmune blistering skin diseases. Autoimmun Rev. 2010; 10:84–89. PMID:
20713186.
Article
9. Labib RS, Anhalt GJ, Patel HP, Mutasim DF, Diaz LA. Molecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting. J Immunol. 1986; 136:1231–1235. PMID:
2418109.
10. Kasperkiewicz M, Zillikens D. The pathophysiology of bullous pemphigoid. Clin Rev Allergy Immunol. 2007; 33:67–77. PMID:
18094948.
Article
11. Büdinger L, Borradori L, Yee C, Eming R, Ferencik S, Grosse-Wilde H, et al. Identification and characterization of autoreactive T cell responses to bullous pemphigoid antigen 2 in patients and healthy controls. J Clin Invest. 1998; 102:2082–2089. PMID:
9854043.
Article
12. Romagnani S. Human TH1 and TH2 subsets: regulation of differentiation and role in protection and immunopathology. Int Arch Allergy Immunol. 1992; 98:279–285. PMID:
1422257.
Article
13. Delgado JC, Turbay D, Yunis EJ, Yunis JJ, Morton ED, Bhol K, et al. A common major histocompatibility complex class II allele HLA-DQB1* 0301 is present in clinical variants of pemphigoid. Proc Natl Acad Sci U S A. 1996; 93:8569–8571. PMID:
8710911.
Article
14. Esmaili N, Mortazavi H, Chams-Davatchi C, Daneshpazhooh M, Damavandi MR, Aryanian Z, et al. Association between HLA-DQB1*03:01 and Bullous pemphigoid in Iranian patients. Iran J Immunol. 2013; 10:1–9. PMID:
23502333.
15. Okazaki A, Miyagawa S, Yamashina Y, Kitamura W, Shirai T. Polymorphisms of HLA-DR and -DQ genes in Japanese patients with bullous pemphigoid. J Dermatol. 2000; 27:149–156. PMID:
10774139.
Article
16. Gao XH, Winsey S, Li G, Barnardo M, Zhu XJ, Chen HD, et al. HLA-DR and DQ polymorphisms in bullous pemphigoid from northern China. Clin Exp Dermatol. 2002; 27:319–321. PMID:
12139680.
Article
17. Lin MS, Fu CL, Giudice GJ, Olague-Marchan M, Lazaro AM, Stastny P, et al. Epitopes targeted by bullous pemphigoid T lymphocytes and autoantibodies map to the same sites on the bullous pemphigoid 180 ectodomain. J Invest Dermatol. 2000; 115:955–961. PMID:
11121125.
Article
18. Dabelsteen E, Ullman S, Thomsen K, Rygaard J. Demonstration of basement membrane autoantibodies in patients with benign mucous membrane pemphigoid. Acta Derm Venereol. 1974; 54:189–192. PMID:
4134127.
19. Weber R, Monteiro F, Preuhs-Filho G, Rodrigues H, Kalil J, Miziara ID. HLA-DRB1*04:02, DRB1*08:04 and DRB1*14 alleles associated to pemphigus vulgaris in southeastern Brazilian population. Tissue Antigens. 2011; 78:92–93. PMID:
21554253.
Article